2008
DOI: 10.1016/j.atherosclerosis.2007.08.018
|View full text |Cite|
|
Sign up to set email alerts
|

RETRACTED: Phytoestrogen α-zearalanol inhibits homocysteine-induced endothelin-1 expression and oxidative stress in human umbilical vein endothelial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
15
0
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 17 publications
1
15
0
1
Order By: Relevance
“…Moreover, sustained exposure to the endothelial cells to high levels of Hcy contribute to endothelial dysfunction. 9 ROS oxygen species are known to modulate cellular functions resulting in a diseased cell. Our study suggests that ROS levels are increased in females with unexplained fertility.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, sustained exposure to the endothelial cells to high levels of Hcy contribute to endothelial dysfunction. 9 ROS oxygen species are known to modulate cellular functions resulting in a diseased cell. Our study suggests that ROS levels are increased in females with unexplained fertility.…”
Section: Discussionmentioning
confidence: 99%
“…There are reports that homocysteine increases inducible NO synthase (iNOS) expression and 3-NT formation in endothelial cells in vitro , and the enhanced nitrative stress plays an important role in homocysteine-induced endothelial dysfunction [8, 9]. Duan et al [29] had reported that α -ZAL may antagonize homocysteine-induced ROS accumulation, which may contribute to α -ZAL-induced beneficial effect on endothelial function. Based on these pieces of work, we further explored whether α -ZAL might inhibit the nitrative stress in homocysteine-treated HUVECs or not.…”
Section: Discussionmentioning
confidence: 99%
“…However, in vascular endothelium, many studies have demonstrated the inhibition of ET-1 expression by estrogens [46,47], a mechanism that may explain the well-known vasoprotective estrogen effects [47].Fulvestrant in contrast to tamoxifen left gene expression of the ET system unaffected, supporting the perception of fulvestrant as the clinically superior compound. Different from the SERM tamoxifen, fulvestrant is an ER antagonist and ER downregulator without agonistic activity [48].…”
Section: Discussionmentioning
confidence: 99%